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Available online ▪ ▪ ▪AbstractObjective: To analyze the correlations between CT features and clinical characteristics in HIV-negative patients with pulmonary cryptococcosis.
Methods: Medical records of 16 HIV-negative patients with pulmonary cryptococcosis diagnosed at our institution were retrospectively
analyzed. CT examinations were obtained with a multidetector row CT scanner. The clinical characteristics of 7 patients with nodules or masses
without ground-glass opacity (GGO)/consolidation type were compared with those of 9 patients with inclusive GGO or consolidation type.
Results: Host status was immunocompromised (81.2%) in most of the patients. 6 (37.5%) patients were asymptomatic. The most frequent CT
findings were one or more nodules (87.5%), GGO (42.9%), and consolidations (18.8%). Most lesions were located in the lower lobes. The levels
of hemoglobin (12.0 [8.9e16.5] vs 8.4 [4.4e14.9]) and platelets (24.6 [10.2e36.0] vs 8.4 [1.4e30.3]) were significantly lower in patients with
inclusive GGO or consolidation type compared with those of patients without GGO or consolidation (p ¼ 0.044 and p ¼ 0.023, respectively).
There was no statistically significant difference in sex, age, host status, body mass index, symptoms at initial consultation, HbA1c, WBC,
lymphocytes, albumin, ESR, CRP, and IgG.
Conclusions: GGO or consolidation was more common in HIV-negative patients with cryptococcosis when they suffered from anemia and
thrombocytopenia.
© 2016 Beijing You'an Hospital affiliated to Capital Medical University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cryptococcosis, which occurs sporadically worldwide, is a
potentially serious fungal disease that is typically caused by
inhalation of Cryptococcus neoformans or C.gattii, which
tends to form an aerosol [1]. The fungus most commonly in-
fects patients with human immunodeficiency virus (HIV) and* Corresponding author. Tel./fax: þ86 020 85253108.
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fects immunocompetent patients. The respiratory tract is
thought to be the entry site and is the organ most frequently
involved when cryptococcal infection develops [2,3]. The
presentation of pulmonary cryptococcosis can range from
asymptomatic nodular disease to severe acute respiratory
distress syndrome (ARDS). In an immunocompetent host the
pulmonary infections normally are asymptomatic, different
from the immunocompromised patient, in which cryptococcal
infections often cause symptomatic infection, often dissemi-
nate to the central nervous system, skin, and bones.
The CT findings of pulmonary cryptococcosis are varied.
Well-defined single or multiple pulmonary nodules are thetomography features and clinical characteristics in HIV-negative patients with
.org/10.1016/j.jrid.2016.05.001
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infiltrates. Furthermore, cavitation within nodules and paren-
chymal consolidation are more common in immunocompro-
mised than in immunocompetent patients [3]. K. Kishi et al.
reported that ground-glass opacity (GGO) or consolidation
may be a radiological finding of pulmonary cryptococcosis
[4]. They also reported that there might be a correlation be-
tween CT features and clinical characteristics in patients with
GGO and patients without GGO. But the correlation is not
clear. So far few investigations have compared the lesions
with/without GGO and clinical characteristics of pulmonary
cryptococcosis in non-HIV patients [5e8]. As a result, we
retrospectively reviewed pulmonary cryptococcosis patients
and assessed the correlation between chest CT features and
clinical characteristics.
2. Material and methods
This was a retrospective study in which clinical data were
collected from patient medical records. Baseline clinical
measurements were obtained within 7 days of the diagnosis of
pulmonary cryptococcosis. We studied 16 HIV-negative pa-
tients with pulmonary cryptococcosis diagnosed by histolog-
ical or cytological presence of the organism in lung biopsy
specimens, by positive findings from culture of respiratory
specimens, or by a positive result of the serum cryptococcal
antigen test with radiographic evidence of pulmonary disease.
The patients were diagnosed at our institution from January
2010 to January 2015.
Ten patients were men and 6 were women, with a median
age of 60 [range: 25e82] years. Host status was immuno-
compromised in 81.2% of the patients, of whom 5 patients had
hematologic malignancy, 3 patients received corticosteroid
and/or other immunosuppressive drugs for myasthenia gravis,
2 patients with advanced solid tumor, 2 patients received
corticosteroid for chronic nephritis, and 1 patient received
renal transplantation. 87.5% of patients did not have impaired
glucose tolerance (hemoglobin A1c (HbA1c) < 6.5%), and 6
(37.5%) were asymptomatic. Fever and cough were the most
common presenting symptoms, followed by general fatigue.
Elevation of the peripheral white blood cell (WBC) count was
detected in 6 patients (36.5%) (normal range: 3200e9000/mL).
A lymphocyte cell count of <1000/mL was present in 7
(43.8%) patients, a hemoglobin (Hb) of <10 g/dL in 7 (43.8%)
patients, a platelet count (Plt) of <15.0  104/mL in 7 (43.8%)
patients, an albumin level of <3.0 g/dL in 6 (36.5%) patients,
and a low immunoglobulin G (IgG) of <800 mg/dL) in 6
(36.5%) patients. All patients were positive for cryptococcal
antigen titer.
The diagnosis of pulmonary cryptococcosis was made by
direct tissue examination in 5 patients (transbronchial lung
biopsy in 4 and video-assisted thoracoscopic surgery in 1), and
by cytology from bronchial brushings and washing in 2 pa-
tients. The other 9 patients were diagnosed clinically by the
positive result of a serum cryptococcal antigen test with
radiographic evidence of pulmonary disease. Treatment
included antifungal drugs alone in 10 patients, surgery plusPlease cite this article in press as: Wang Y-h, et al., Correlation between computed
pulmonary cryptococcosis, Radiology of Infectious Diseases (2016), http://dx.doiantifungal therapy in 1, and none in 4 patients. Of the 11
patients who received antifungal therapy, 10 patients
improved, and 1 died due to underlying disease during the
follow-up period. Underlying disease in the 4 patients who
received no treatment (hematological malignancy in 3 and
pancreatic cancer in 1) progressed rapidly, and antifungal
treatment was impossible.
CT examinations were obtained with a multidetector row
CT scanner (Lightspeed Qx/i; GE Medical Systems, Mil-
waukee, WI). Imaging parameters were as follows: 120 kVp,
180 mAs, 1.25-mm collimation and a pitch of 1.5. The
reconstructed slice thickness and interval were 3 mm. The
routine chest CT images were obtained from the lung apices
through the bases. Images were viewed on standard lung
windows (level 600 HU; width 1500 HU) and mediastinal
windows (level 40 HU; width 400 HU).
The chest CT images were analyzed by consensus by two
radiologists (JQ and YW, with 15 and 10 years of experience
in chest imaging, respectively). They were blinded to the
diagnosis or clinical data. A consensus reading of the CT
images was conducted by two observers. The findings and
interpretations were based on their consensus opinion. CT
images were assessed for the following patterns of pulmonary
abnormality: nodules, GGO, and consolidations. Consolida-
tion was considered to be present when the opacities obscured
the underlying vessels. Nodules were defined as <3 cm in
diameter and a mass was defined as 3 cm in diameter.
Ground-glass opacity was defined as hazy increased attenua-
tion of the lung without obscuration of the bronchial and
vascular margins.
In order to analyze the correlations between CT features
and clinical characteristics in HIV-negative patients with
pulmonary cryptococcosis, we divided the patients into two
groups: 7 patients with nodules or masses without GGO/
consolidation type; 9 patients with inclusive GGO or consol-
idation type.
Data are presented as median [range] unless otherwise
stated. Fisher's exact test or ManneWhitney U test was used
for between-group comparisons with nominal and continuous
variables, respectively. A p value < 0.05 was considered
statistically significant. Missing data were categorized as
“unknown” and were entered into each statistical analysis
model. All data were analyzed with SPSS version 20.0 for
windows.
3. Results3.1. Clinical characteristicsThe clinical characteristics of the 7 patients with a nodule
or mass without GGO/consolidation type were compared
with those of the 9 patients with inclusive GGO or consoli-
dation type and are were summarized in Table 1. Neither sex,
age, host status, body mass index (BMI), symptoms at initial
consultation nor HbA1c, WBC, lymphocytes, albumin, ESR,
CRP, IgG were significantly different between the two
groups.tomography features and clinical characteristics in HIV-negative patients with
.org/10.1016/j.jrid.2016.05.001
Table 2
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CT features of pulmonary abnormalities.
Abnormality n (%)
Pulmonary nodules 14 (87.5)
Solitary 3 (18.8)
Multiple 11 (68.7)
5-10 5 (31.3)
> 10 0 (0)
Ground-glass opacity 6 (42.9)
Consolidations 3 (18.8)
Pleural effusion 4 (25.0)
Calcification 1 (6.3)
Lesion area
Right lung 13 (81.3)
Left lung 8 (50.0)
Bilateral lungs 5 (31.3)
Lesion area
Upper lung 6 (42.9)
Middle lung 3 (18.8)
Lower lung 10 (62.5)
Extent of lesions (5 pulmonary lobes)
1/2/3 10 (62.5)/5 (31.3)/1 (6.3)
>4 0 (0)The pulmonary abnormalities seen on the initial CT scans
are summarized in Table 2. No patient had extra thoracic
cryptococcosus. The most common CT findings were one or
more pulmonary nodules (87.5%). A solitary nodule was seen
in 18.8% (Fig. 1A) and multiple nodules in 68.7% (Fig. 1B) of
patients. The second most common finding was GGO (42.9%)
(Fig. 2A). Other associated findings included consolidations
(18.8%) (Fig. 2B), pleural effusion (25.0%), and calcification
(6.3%). Lesions in the right lung were present in 13 (81.3%)
patients, in the left lung in 8 (50.0%) patients, and in bilat-
erally in 5 (31.3%) patients, of whom the lesions were more
frequent in the right lung. 10 (62.5%) patients had lesion
involvement in the lower lobe, 6 (42.9%) patients had upper
lobe involvement, and 3 (18.8%) patients had middle lobe
involvement, which was more frequent in the lower lobe.
Lesion extent was evaluated in the pulmonary lobes, including
the upper, middle, and lower lobes in the right lung, and the
upper lingular and lower lobes in the left lung. Most lesions
(62.5%) were located in one lobe, and no lesions were located
in 4 or more lobes.3.3. Correlation between CT features and clinical
characteristicsThe hemoglobin (12.0 [8.9e16.5] vs 8.4 [4.4e14.9]) and
platelets (24.6 [10.2e36.0] vs 8.4 [1.4e30.3]) were signifi-
cantly lower in patients with inclusive GGO or consolidation
type compared with those of patients without GGO orTable 1
Clinical characteristics of patients with a nodule or mass without GGO/consolidat
Clinical characteristics Nodule or mass without
GGO/consolidation type
Male 5 (71.4%)
Age (years) 73 [25e82]
>70 years 4 (57.1%)
Immunocompromised 5 (71.4%)
BMI, kg/m2 19.6 [16.0e24.0]
<18.5 kg/m2 2 (28.6%)
No Symptoms 3 (42.9%)
HbA1c (%) 5.8 [5.1e6.5]
WBC (/mL) 7400 [6400e12,300]
Lym (/mL) 1300 [600e2900]
<1000/mL 2 (28.6%)
Hb (g/dL) 12.0 [8.9e16.5]
<10.0 mg/dL 1 (14.3%)
Plt (104/mL) 24.6 [10.2e36.0]
<10.0  104/mL 0 (0%)
Albumin (g/dL) 3.3 [2.5e4.9]
<3.0 g/dL 1 (14.3%)
ESR (mm/hr) 10 [1e62]
CRP (mg/dL) 0.5 [0.1e7.0]
1.0 mg/dL 1 (14.3%)
IgG (mg/dL) 885 [467e2507]
<800 mg/dL 3 (42.9%)
Values are shown as median [range] or number (%). Statistically significant p-valu
Abbreviations: GGO: ground-glass opacity, BMI: body mass index, HbA1c: hemogl
platelet, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, IgG: immu
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or consolidation was more common in HIV-negative patients
with cryptococcosis when they suffered from anemia and
thrombocytopenia.
4. Discussion
Cryptococcosis typically occurs in immunocompromised
patients such as those with HIV/AIDS, and the presence ofion type and with inclusive GGO or consolidation type.
Inclusive GGO or
consolidation type
P Value
5 (55.5%) 0.633
60 [56e79] 0.873
4 (44.4%) 0.999
8 (88.9%) 0.550
22.1 [17.6e25.0] 0.153
1 (11.1%) 0.550
3 (33.3%) 0.999
5.5 [4.9e7.0] 0.943
8100 [1500e31,400] 0.427
600 [230e2200] 0.265
5 (55.6%) 0.358
8.4 [4.4e14.9] 0.044
6 (66.7%) 0.060
8.4 [1.4e30.3] 0.023
5 (55.6%) 0.034
2.9 [2.4e3.9] 0.184
5 (55.6%) 0.145
74 [10e78] 0.176
1.4 [0.1e6.7] 0.310
6 (66.7%) 0.060
983 [410e4121] 0.897
3 (37.5%) 0.999
es are shown in bold.
obin A1c, WBC: white blood cell, Lym: lymphocyte cell, Hb: hemoglobin, Plt:
noglobulin G.
tomography features and clinical characteristics in HIV-negative patients with
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Fig. 1. Pulmonary cryptococcosis of the nodule without GGO/consolidation type. One patient showed a solid nodule without spiculation in the left lower lobe (A).
Another patient showed two nodules in the right lower lobe (B).
Fig. 2. Pulmonary cryptococcosis in inclusive GGO or consolidation type. One patient showed multiple nodules with GGO in the left lung (A). Another patient
showed multiple nodules, consolidation, and pleural effusion in the right lower lobe (B).
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ated with high mortality [9,10]. The clinical descriptions of
pulmonary cryptococcosis in HIV-negative individuals are
quite limited because of the rarity of the disease itself. In
general, males are more frequently infected than females
[11,12]. In the present study, the disease also occurred pre-
dominantly in males. Nadrous et al. reported that about one-
third of immunocompetent patients with pulmonary crypto-
coccosis were asymptomatic [13]. Although the present study
comprised predominantly immunocompromised patients
(81.2%), a similar ratio of asymptomatic patients was alsoPlease cite this article in press as: Wang Y-h, et al., Correlation between computed
pulmonary cryptococcosis, Radiology of Infectious Diseases (2016), http://dx.doiobserved, indicating that even asymptomatic patients with
immunodeficiency require attention.
The CT features of pulmonary cryptococcosis were vari-
able. Most of our patients (87.5%) had pulmonary nodules
(solitary: 18.8%, multiple: 68.7%). The high frequency of
these lesions was consistent with that reported by other studies
[8,11,12,14,15]. The lesions were located predominantly in the
lower lung (62.5%) rather than in the middle (18.8%) or upper
lung (42.9%), which was also been noted in other studies
[11,12,16,17], and were found mainly in the right (81.3%)
rather than the left (50.0%) lung in most patients. Most lesionstomography features and clinical characteristics in HIV-negative patients with
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present in 4 or more lobes.
We investigated the correlation between clinical charac-
teristics and chest CT features in the patients with pulmonary
cryptococcosis. GGO lesions and consolidations of pulmonary
cryptococcosis appear to occur more frequently in immuno-
compromised hosts [3]. Individuals with macrophages, helper
T cells, natural killer cells, and others are related to infection
with C. neoformans [18]. We found GGO lesions in 42.9% and
consolidations in 18.8% of the patients. Inclusive GGO or
consolidation type was more frequent in the immunocom-
promised hosts (88.9%), but the frequency of lesions without
GGO/consolidation type in these hosts was nearly the same
(71.4%). Generally, an “immunocompromised host” refers to a
patient with malignant disease or who has received an
immunosuppression drug, has undergone an enforced trans-
plantation, has severe diabetes, or is immunodeficient, but the
definition of “immunocompromised host” is not yet clear.
Therefore, we thought that the assessment of clinical data and
radiological features related to pulmonary cryptococcosis may
be useful because non-HIV patients also have pulmonary
cryptococcosis. Results of routine laboratory investigations in
another study were generally nonspecific [7]. The levels of Hb
and Plt were significantly lower in the patients with inclusive
GGO or consolidation type than in those with nodule or mass
without GGO/consolidation type. Although approximately one
third of our patients had hematologic malignancy, the
lymphocyte cell count and IgG level as indices of immuno-
suppression were not significantly difference between the two
disease types. Therefore, the CT findings of pulmonary cryp-
tococcosis in patients with anemia and thrombocytopenia
might indicate GGO or consolidation.
There are some reports on the distinction between
immunocompetent and immunocompromised patients. Xie
et al. found that cavitations within nodules/masses were more
commonly seen in immunocompromised patients, especially
AIDS patients, while air bronchograms were more commonly
seen in immunocompetent patients [11]. The same as we
found in our patients. In the present manuscript, we mainly
analyzed and focused on the correlations between CT fea-
tures and clinical characteristics in HIV-negative patients
with pulmonary cryptococcosis. So we did not divide the
patients into groups with immunocompromised and
competent.
A limitation of this study is that it is a retrospective, single-
site study with a small number of patients collected over a
long period, and our results should not be generalized to the
worldwide population. Further studies are needed to clarify the
correlation between CT findings and clinical characteristics in
patients with pulmonary cryptococcosis.
5. Conclusion
We conclude that GGO or consolidation was more common
in HIV-negative patients with cryptococcosis when they suf-
fered from anemia and thrombocytopenia.Please cite this article in press as: Wang Y-h, et al., Correlation between computed
pulmonary cryptococcosis, Radiology of Infectious Diseases (2016), http://dx.doiAcknowledgment
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